Abstract
Cell kinetics of human carcinoma xenografts and human solid tumors were evaluated by means of two‐color flow cytometry using single sampling at appropriate time intervals after bromodeoxyuridine (BrdU) labeling. The tumors were resected several hours after the administration of BrdU, and flow cytometry was used to measure the DNA content and BrdU incorporation. Once the BrdU labeling index (LI) and DNA synthesis time (Ts) were obtained, the potential doubling time (Tpot) was calculated from these values. In 11 xenografts, the cell kinetic data were compared with the actual tumor doubling time (Td), and a good correlation between Tpot and Td was obtained (r=0.91, P< 0.005). In a clinical study, 33 patients with gastric cancer, colorectal cancer, lung cancer, or other solid tumors were analyzed. Aneuploid tumors had a significantly higher LI value (P< 0.01) and a shorter Tpot than diploid tumors. The cell loss rate of human tumors ranged from 40% to 80%. These cell kinetic parameters therefore accurately indicated the level of proliferative activity of human tumors.
Keywords: Proliferative activity, Flow cytometry, Bromodeoxyuridine, Potential doubling time, Tumor doubling time
Full Text
The Full Text of this article is available as a PDF (320.1 KB).
REFERENCES
- 1. ) Steel , G. G. and Hanes , S.The technique of labelled mitosis: analysis by automatic curve‐fitting . Cell Tissue Kinet. , 4 , 93 – 105 ( 1971. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Terz , J. J. , Curutchet , H. P. and Lawrence , W.Analysis of the cell kinetics of human solid tumors . Cancer , 28 , 1100 – 1110 ( 1971. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Meyer , J. S. and Prioleau , P. G.S‐Phase fractions of colorectal carcinomas related to pathologic and clinical features . Cancer , 48 , 1221 – 1228 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Sano , K. , Sato , F. , Hoshino , T. and Nagi , M.Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BrdU‐antimetabolite continuous regional infusion‐radiation therapy . Neural. Med. Chir. , 7 , 51 – 62 ( 1965. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Kinsella , T. J. , Mitchell , J. B. , Russo , A. , Aiken , M. , Mortyn , G. , Hsu , S. M. , Rawland , J. and Glatstein , E.Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer . J. Clin. Oncol , 2 , 1144 – 1150 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Phuphanich , S. , Levin , E. M. and Levin , V. A.Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors . Int. J. Radial. Oncol. Biol. Phys. , 10 , 1769 – 1772 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Gratzner , H. G.Monoclonal antibody to 5‐bromo and 5‐iododeoxyuridine . Science , 218 , 474 – 475 ( 1982. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Dolbeare , F. , Gratzner , H. , Pallavicini , M. G. and Gray , J. W.Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine . Proc. Natl. Acad. Sci. USA , 80 , 5573 – 5577 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. ) Begg , A. C. , McNally , N. J. , Shrieve , D. C. and Karcher , H.A method to measure the duration of DNA synthesis and potential doubling time from a single sampling . Cytometry , 6 , 220 – 226 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Donova , M. , Wilson , G. , Riccardi , A. , Mazzini , G. and Ucci , G.In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic study in human malig nancies . Haematologica , 72 , 115 – 119 ( 1987. ). [PubMed] [Google Scholar]
- 11. ) Donova , M. , Riccardi , A. , Gaetani , P. and Wilson , G. D.Cell kinetics of brain tumors: in vivo study with bromodeoxyuridine and flow cytometry . Eur. J. Clin. Oncol. , 24 , 873 – 880 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Riccardi , A. , Donova , M. , Wilson , G. and Ucci , G.Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry . Cancer Res. , 48 , 6238 – 6245 ( 1988. ). [PubMed] [Google Scholar]
- 13. ) Stephenson , R. A. , James , B. C. , Gay , H. , Fair , W. R. , Whitmore , W. F. and Melamed , M. R.Flow cytometry of prostatic cancer: relationship of DNA content to survival . Cancer Res. , 47 , 2504 – 2509 ( 1987. ). [PubMed] [Google Scholar]
- 14. ) Volm , M. , Bruggemann , A. , Gunther , M. , Kleine , M. , Pfeiderer , A. and Vogt , S. M.Prognostic relevance of ploidy, proliferation, and resistance‐predictive tests in ovarian carcinoma . Cancer Res. , 45 , 5180 – 5185 ( 1985. ). [PubMed] [Google Scholar]
- 15. ) Fabricant , J. I. , Wisseman , C. I. and Vitak , M.The kinetics of cellular proliferation in normal and malignant tissues . Radiology , 92 , 1309 – 1320 ( 1969. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Thomas , D. W. and Williams , E. D.Use of bromodeoxyuridine for cell kinetic studies in intact animals . Ceil Tissue Kinet. , 19 , 179 – 182 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Hoshino , T. , Nagashima , T. , Muroric , J. A. and Wilson , C. B.Proliferative potential of human meningiomas of brain. A cell kinetics study with bromodeoxyuridine . Cancer , 58 , 1466 – 1472 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Dean , P. N. , Dolbeare , F. , Gratzner , H. and Pice , G. C.Cell cycle analysis using a monoclonal antibody to BrdUrd . Cell Tissue Kinet. , 17 , 427 – 436 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Tsurusawa , M. , Niwa , M. , Katano , N. and Fujimoto , T.Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate‐treated mouse L1210 leukemic cells . Cancer Res. , 48 , 4288 – 4293 ( 1988. ). [PubMed] [Google Scholar]
- 20. ) Francfurt , O. S. , Greco , W. R. , Slocurn , H. K. , Arbuck , S. G. , Gamarra , M. , Pavelic , Z. P. and Rustum , Y. M.Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry , Cytometry , 5 , 629 – 635 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Tsuchihashi , Y. and Mitsufuji , S.In vitro BrdU‐labelling of human specimens using perfluorotributylamine emulsion . Igaku no Ayumi , 149 , 619 – 622 ( 1989. ) ( in Japanese ). [Google Scholar]
- 22. ) Ruffolo , P. R. and Ferm , V. H.The embryonal and teratogenic effects of 5‐bromodeoxyuridine in pregnant hamster . Lab. Invest. , 14 , 1547 – 1553 ( 1965. ). [PubMed] [Google Scholar]
- 23. ) Napalkov , N. P. , Anisimov , V. N. , Likahachev , A. J. and Thomatis , L.5‐Bromodeoxyuridine‐induced carcinogenesis and its modification by persistent estrus syndrome, unilateral nephrectomy, and X‐irradiation in rats . Cancer Res. , 49 , 318 – 323 ( 1989. ). [PubMed] [Google Scholar]
- 24. ) Joseph , H. and Joseph , P.In vivo studies of DNA synthesis in human normal cells and tumor cells . Cancer Res. , 27 , 808 – 902 ( 1967. ). [PubMed] [Google Scholar]
- 25. ) Steel , G. G.Cell loss as a factor in the growth rate of human tumors . Eur. J. Cancer , 3 , 381 – 387 ( 1967. ). [DOI] [PubMed] [Google Scholar]
- 26. ) Camplejohn , R. S. , Bone , G. and Aherne , W.Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic study . Eur. J. Cancer , 9 , 577 – 581 ( 1973. ). [DOI] [PubMed] [Google Scholar]